NASDAQ

Design Therapeutics, Inc. (DSGN)

♥ 615 Thanks from members

Live price chart, market sentiment, and community perspectives for Design Therapeutics, Inc. (NASDAQ: DSGN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Sir Dr. Richard HendersonFounder: Alexis BorisyLeadership: Sonia Poli (Chief Scientific Officer)Holder: Arch Venture PartnersHolder: Boxer CapitalHolder: Fidelity ManagementGene-targeted small molecule therapeutics#DSGN#Design Therapeutics#Genomic Medicine#Biotech#Gene Modulation